首页> 外文期刊>Canadian family physician: Medecin de famille canadien >Henoch-Sch?nlein purpura in children: Limited benefit of corticosteroids
【24h】

Henoch-Sch?nlein purpura in children: Limited benefit of corticosteroids

机译:儿童过敏性紫癜:皮质类固醇激素获益有限

获取原文
获取原文并翻译 | 示例
           

摘要

Question A child recently presented to my office with lower limb petechiae, arthralgia, and abdominal pain characteristic of Henoch-Sch?nlein purpura (HSP). Will systemic corticosteroids help relieve these symptoms and prevent potential HSP complications such as intussusception and nephritis?Answer Henoch-Sch?nlein purpura is a common and self-limiting disease in children. Current evidence does not support universal treatment of HSP with corticosteroids. Recent trials and meta-analyses found that corticosteroids do not prevent the onset of renal disease or abdominal complications. However, corticosteroids are effective as treatment of abdominal pain, arthralgia, and purpura. Clinicians are advised to use their discretion in choosing which patients might benefit most from oral corticosteroid treatment.
机译:问题最近有一个孩子出现在我的办公室,出现下肢瘀点,关节痛和过敏性紫癜(HSP)的腹部疼痛。全身性皮质类固醇激素能帮助缓解这些症状并预防潜在的HSP并发症如肠套叠和肾炎吗?过敏性紫癜是儿童的一种常见且自限性疾病。目前的证据不支持用糖皮质激素普遍治疗HSP。最近的试验和荟萃分析发现,皮质类固醇不能预防肾病或腹部并发症的发作。然而,皮质类固醇可有效治疗腹痛,关节痛和紫癜。建议临床医生根据自己的判断,选择哪些患者可能会从口服糖皮质激素治疗中受益最大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号